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EDITORIAL
Research in the time of COVID
The impact of the SARS-CoV-2 (COVID-
19) is indescribable. On 11 October
2020, there were 37, 259, 238 confirmed
cases and 1, 073, 751 deaths recorded
across the globe [1]. As such, the pan-
demic continues to rage and shows little
sign of abating. Indeed, with the reality
of a second wave upon us, the world
seems a very different place today compared with just
nine months ago.
The European Journal of General Practice has provided
commentary on the impact on clinical services in primary
care [2] and rapidly published ‘lessons learned’ from
across Europe [3–6]. We have discussed what happens
after the first wave and emphasised the widespread
impact on our vulnerable patients [7]. In this editorial, we
address another impact of the coronavirus pandemic
– research.
Primary care has worked hard to establish a strong,
vibrant and thriving research environment that addresses
the types of clinical problems encountered by people on
a daily basis. Whilst our subject matter may not always
be the top priority for funders or policymakers, common
complaints, such as back pain, constipation and eczema
cause real problems for people and impact significantly
on their quality of life. Providing a robust evidence base
to optimise care in these areas and others is critical for
general practice.
COVID has had a huge impact on non-COVID research.
Through absolute necessity, huge portfolios of primary
care research shut down overnight as health services and
research teams were diverted to provide front line clinical
care. It was not safe to recruit participants to studies
using conventional measures and patients were advised
to stay at home whenever possible. As COVID-19 related
research, such as vital vaccine studies, have been rapidly
funded, delivery teams have reprioritised activity, delay-
ing the restart of research in other clinical areas.
I am not at all critical of these decisions. This had to
happen. But what can we learn and how can
move forward?
General practice and general practice research are
hugely innovative, although sometimes we all need that
little nudge to change the way how we do things, espe-
cially when the current system seems to work well. Social
distancing makes face to face data collection challenging
and with no end in sight we need to think differently.
We need to invest in technology to allow us to maintain
a strong research base for those with long term
conditions. As the ageing population (and the research
community) become more digitally literate, online data
collection becomes increasingly acceptable and has less
potential to exclude marginalised groups (although this
clearly remains an issue for some). Innovative data collec-
tion methods, such as netnography (an extension of
ethnographic methods that has been adapted allowing it
to be used online), can bring a different perspective to
our research, reaching people who have never previously
engaged in research. Virtual focus groups often allow
more people to contribute, can provide clearer transcripts
than audiotaped research and may be more accessible
for hard to reach populations. Telephone interviews can
be more convenient for participants (and academics)
whilst allowing sampling of a more diverse and geo-
graphically dispersed population and interventions in
clinical trials are being redesigned to delivered remotely.
Clearly there are downsides to all these methods but if
primary care research is to continue we need to rapidly
adapt – and we need our governance structures and
funders to be responsive to these essential changes.
General practice also has a significant role to play in
supporting ongoing COVID-19 research. Where better to
recruit patients to vaccine studies than primary care? We
have outstanding relationships with patients who are
truly representative of the broader population. Primary
care is a convenient setting to recruit participants where
practitioners are widely trusted and respected. We have
expertise in monitoring adverse events and increasingly
sophisticated electronic health records that can rapidly
provide accurate and contemporary data on medication,
morbidity and key lifestyle demographics to inform
research. All of these resources will be invaluable to the
ongoing battle against COVID-19.
General practice is also critical to leading research into
the long term impacts of coronavirus (‘long COVID’).
Increasingly, people who have been diagnosed with
COVID-19 are reporting a range of diverse and persistent
symptoms including breathlessness, muscle pain, rashes,
memory problems and tiredness. Recovery is prolonged
for many, with long term consequences unlikely to be
fully known for many years. The long term mental health
impact of the pandemic is going to be huge. Not only
will general practice be at the front line of managing
these problems, we will also need to be leading the
research in this area in a way only the generalist can.
General practice has adapted rapidly to provide critical
health care provision to our patients during the pan-
demic. Now let’s also think about how we can work
EUROPEAN JOURNAL OF GENERAL PRACTICE
2020, VOL. 26, NO. 1, 154–155
https://doi.org/10.1080/13814788.2020.1838184
differently to support the research which underpins our
patient care.
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